NCT00046514View on ClinicalTrials.gov

ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2001

Conditions
Breast NeoplasmsMetastases, Neoplasm
Interventions
DRUG

ABI-007

Trial Locations (1)

27609

Abraxis BioScience, Inc., Raleigh

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY